153 related articles for article (PubMed ID: 3086885)
1. Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugates.
Jung G; Honsik CJ; Reisfeld RA; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4479-83. PubMed ID: 3086885
[TBL] [Abstract][Full Text] [Related]
2. Activation of autoreactive cytolytic T lymphocyte clone against human melanoma by anti-T3 monoclonal antibody and autologous accessory cells.
Tatake RJ; Guha A; Mukherji B
Cell Immunol; 1987 Aug; 108(1):42-52. PubMed ID: 3111724
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous human T-cell cytotoxicity against murine hybridomas expressing the OKT3 monoclonal antibody: comparison with natural killer cell activity.
Itoh K; Balch CM; Platsoucas CD
Cell Immunol; 1987 Sep; 108(2):313-22. PubMed ID: 3113742
[TBL] [Abstract][Full Text] [Related]
4. Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3.
Jung G; Martin DE; Müller-Eberhard HJ
J Immunol; 1987 Jul; 139(2):639-44. PubMed ID: 3110277
[TBL] [Abstract][Full Text] [Related]
5. Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates.
Jung G; Ledbetter JA; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4611-5. PubMed ID: 3110771
[TBL] [Abstract][Full Text] [Related]
6. Induction of nonspecific cytotoxicity by monoclonal anti-T3 antibodies.
Leeuwenberg JF; Spits H; Tax WJ; Capel PJ
J Immunol; 1985 Jun; 134(6):3770-5. PubMed ID: 2580895
[TBL] [Abstract][Full Text] [Related]
7. Activation of human T lymphocytes. III. Triggering of bystander cytotoxicity in cytotoxic T cell clones by antibodies against the T3 antigen or by a calcium ionophore.
Schrezenmeier H; Kurrle R; Wagner H; Fleischer B
Eur J Immunol; 1985 Oct; 15(10):1019-24. PubMed ID: 3932080
[TBL] [Abstract][Full Text] [Related]
8. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
[TBL] [Abstract][Full Text] [Related]
9. Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes.
Liu MA; Kranz DM; Kurnick JT; Boyle LA; Levy R; Eisen HN
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8648-52. PubMed ID: 3936039
[TBL] [Abstract][Full Text] [Related]
10. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
11. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
Schwab R; Crow MK; Russo C; Weksler ME
J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
[TBL] [Abstract][Full Text] [Related]
12. Anti-T3 antibody both activates and inhibits the cytotoxic activity of human T cell clones.
Hoffman RW; Quinones RR; Shaw S
Behring Inst Mitt; 1985 Aug; (77):30-8. PubMed ID: 3936472
[TBL] [Abstract][Full Text] [Related]
13. T3 monoclonal antibody activation of nonspecific cytolysis: a mechanism of CTL inhibition.
Mentzer SJ; Barbosa JA; Burakoff SJ
J Immunol; 1985 Jul; 135(1):34-8. PubMed ID: 2582036
[TBL] [Abstract][Full Text] [Related]
14. Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function.
Moretta A; Pantaleo G; Mingari MC; Moretta L; Cerottini JC
J Exp Med; 1984 Mar; 159(3):921-34. PubMed ID: 6421984
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis.
Thiele DL; Patel SS; Lipsky PE
J Immunol; 1988 May; 140(9):3253-60. PubMed ID: 2966209
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
Palacios R
Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
[TBL] [Abstract][Full Text] [Related]
18. Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering.
Platsoucas CD
Eur J Immunol; 1984 Jun; 14(6):566-77. PubMed ID: 6610558
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens.
Platsoucas CD; Good RA
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4500-4. PubMed ID: 6974866
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of cytotoxic T lymphocyte (CTL) clones to inhibition by anti-T3 and anti-T4 (but not anti-LFA-1) monoclonal antibodies varies with the "avidity" of CTL-target interaction.
Shaw S; Goldstein G; Springer TA; Biddison WE
J Immunol; 1985 May; 134(5):3019-26. PubMed ID: 2580011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
